Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety

Details for Australian Patent Application No. 2005325262 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Venkitasamy, Kesavan; Rajeev, Kallanthottathil G.; Manoharan, Muthiah

Agent Griffith Hack

Pub. Number AU-B-2005325262

PCT Pub. Number WO2006/078278

Priority 60/565,627 27.04.04 US; 60/611,532 20.09.04 US

Filing date 27 April 2005

Wipo publication date 27 July 2006

Acceptance publication date 11 August 2011

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2006/078278 Priority application(s): WO2006/078278

11 August 2011 Application Accepted

  Published as AU-B-2005325262

8 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005325265-Systems and methods for harvesting and integrating nanowires

2005325261-Dalbavancin compositions for treatment of bacterial infections